Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVO.L Regulatory News (AVO)

  • There is currently no data for AVO

Update on Investment and Deve

10 Jul 2008 07:00

RNS Number : 7302Y
CareCapital Group plc
10 July 2008
 



For release at 07.00, 10 July 2008

CARECAPITAL GROUP PLC

("CareCapital" or "the Company")

Update on Investment and Development Programme

CareCapital plc (AIM: CARE), the healthcare real estate developer and owner, announces that The Healthcare Property Company Wales Limited - its 50/50 Joint Venture with Gaufron Healthcare - has been selected as preferred developer for a new build primary care project in Brynhyfryd, Swansea.

This 2,550 sqm, £7 million development will house an existing five partner GP practice, further community medical facilities operated by the Local Health board, and a training unit for the Swansea Medical School. It is anticipated that construction works on the project will commence early next year, with completion in the Spring of 2010.

This project is the fourth that CareCapital has won in Wales by competitive bid, and the total development value of these projects now exceeds £30 million. The contracts in Wales have been won with the benefit of support from Norwich Union Commercial Finance; as a provider of senior debt for CareCapital's UK development programme.

CareCapital also announces that its German operation has completed the acquisition of a site in Pankow, Central Berlin for the development of a 3,600 sqm medical office building with an estimated development value on completion of €8.3 million. Pre letting has commenced with the view to starting construction works early next year for completion in January 2010. Senior debt funding for the project has been agreed with APO Bank.

Paul Stacey, Chief Executive of CareCapital commented: "It is very pleasing to have been selected as preferred bidder on the development in Brynhyfryd, further strengthening our portfolio in Wales, in addition to having completed the acquisition of the Pankow site in Berlin. Once again, these projects highlight CareCapital's commitment to expanding its programmes in both the UK and Germany".

For further information please visit www.carecapital.co.uk or contact:

Paul Stacey, Managing Director

Shareen Courtney, Marketing 

Lindsay Mair, Director - Corporate Finance

Simon Hudson, 

Paul Youens, Paul Young

CareCapital Group Plc

Daniel Stewart & Co. Plc

Tavistock Communications

Tel: 020 7034 1949

Tel: 020 7776 6550

Tel: 020 7920 3150

or 07966 477256

pstacey@carecapital.co.uk

lindsay.mair@danielstewart.co.uk

shudson@tavistock.co.uk 

scourtney@carecapital.co.uk

pyouens@tavistock.co.uk

pyoung@tavistock.co.uk

~ ends ~

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEKLFBVDBEBBE
Date   Source Headline
9th May 20247:00 amRNSCancellation - Advanced Oncotherapy Plc
3rd May 20248:54 amRNSFurther update on financing discussions
2nd Apr 20243:50 pmRNSFurther update on financing discussions
29th Feb 20245:19 pmRNSFurther update on financing discussions
1st Feb 20247:00 amRNSFurther update on financing discussions
9th Jan 20249:00 amRNSUpdate on Financing Discussions
23rd Oct 20237:00 amRNSUpdate on Financing and Current Financial Position
17th Jul 20237:00 amRNSRecapitalisation and funding plan, update on FSP
30th Jun 20235:00 pmRNSTotal Voting Rights
30th Jun 20237:30 amRNSSuspension - Advanced Oncotherapy PLC
30th Jun 20237:15 amRNSUpdate on financing, suspension of trading on AIM
29th Jun 20231:35 pmRNSHolding(s) in Company
29th Jun 20239:59 amRNSForm 8.3 - Advanced Oncotherapy PLC
28th Jun 202310:25 amRNSForm 8.3 - Advanced Oncotherapy PLC
27th Jun 202310:29 amRNSForm 8.3 - Advanced Oncotherapy
27th Jun 202310:25 amRNSForm 8.3 - Advanced Oncotherapy
26th Jun 20234:26 pmRNSForm 8.3 - Advanced Oncotherapy
26th Jun 202310:57 amRNSPartial conversion of Convertible Notes
23rd Jun 202311:05 amRNSHolding(s) in Company
23rd Jun 20239:30 amRNSForm 8.3 - Advanced Oncotherapy PLC
20th Jun 20235:28 pmRNSHolding(s) in Company
19th Jun 20235:56 pmRNSPartial conversion of Convertible Notes
19th Jun 20231:48 pmRNSForm 8.3 - Advanced Oncotherapy PLC
16th Jun 20236:23 pmRNSIssue of warrants
13th Jun 202311:46 amRNSForm 8.3 - Advanced Oncotherapy PLC
31st May 20235:57 pmRNSUpdate on financing and convertible notes
30th May 202310:42 amRNSForm 8.3 - Advanced Oncotherapy Plc
24th May 20235:54 pmRNSForm 8 (OPD) Advanced Oncotherapy plc
24th May 20235:29 pmRNSForm 8.3 - Advanced Oncotherapy - Cosylab d.d.
22nd May 20232:59 pmRNSForm 8.3 - Advanced Oncotherapy plc
19th May 202312:09 pmRNSForm 8.3 - Advanced Oncotherapy PLC
17th May 20232:58 pmRNSForm 8.3 - Advanced Oncotherapy plc
15th May 202311:36 amRNSUpdate on Convertible Note & Loan Extension
15th May 20239:19 amRNSForm 8.3 - Advanced Oncotherapy Plc
12th May 202312:53 pmRNSForm 8.3 - Advanced Oncotherapy - Minmetco Limited
11th May 20235:14 pmRNSForm 8.3 - Advanced Oncotherapy - eQ Blue Planet
11th May 202311:17 amRNSForm 8.3 - Advanced Oncotherapy - Atlantic Cedar
10th May 202311:34 amRNSForm 8.3 - Advanced Oncotherapy plc
9th May 20234:40 pmRNSForm 8.3 - Advanced Oncotherapy - Baltisches Haus
9th May 20234:37 pmRNSForm 8.3 - Advanced Oncotherapy plc
9th May 20234:36 pmRNSForm 8.3 - Advanced Oncotherapy plc
5th May 20238:56 amRNSFORM 8.3 - Advanced Oncotherapy
5th May 20237:00 amRNSAdditional funding from Secured Convertible Note
4th May 20235:01 pmRNSForm 8.3 - Advanced Oncotherapy Plc
4th May 20233:55 pmRNSChange of Registered Office
3rd May 20236:19 pmRNSRule 2.9 Announcement
3rd May 20234:28 pmRNSForm 8.3 - Advanced Oncotherapy PLC
2nd May 20236:19 pmRNSForm 8 (OPD) Advanced Oncotherapy plc
18th Apr 20237:00 amRNSStrategic review and formal sale process
31st Mar 20236:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.